He Xiaoning, Chen Liming, Wang Ke, Wu Haiya, Wu Jing
Department of Health Pharmacy and Administration, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin.
Department of Metabolic Disease, Tianjin Medical University Metabolic Diseases Hospital, Tianjin.
Patient Prefer Adherence. 2017 Feb 13;11:237-245. doi: 10.2147/PPA.S123389. eCollection 2017.
To assess adherence and persistence to insulin therapy and identify its associated factors among Chinese insulin-naïve patients with type 2 diabetes (T2D).
Tianjin Urban Employee Basic Medical Insurance claims database was used (2008-2011). Adult patients with T2D who initiated insulin therapy during January 2009 through December 2010 and were continuously enrolled for 12 months pre-(baseline) and 12 months post-initiation (follow-up) were included. Patients who had a ≥80% medication possession ratio were deemed adherent, while patients who had no gaps of ≥90 days in insulin therapy were deemed persistent. Associated factors of insulin adherence and persistence were detected by univariate and multivariate analyses.
A total of 24,192 patients were included; the patients had a mean age of 58.9 years, with 49.5% being female. About 51.9% of the patients had human insulin as initiation therapy, while 39.1% were initiated with insulin analog and 9.0% with animal-derived insulin. Premixed insulin (77.3%) was prescribed most often in comparison with basal (11.8%) and prandial (10.9%) insulin. Only 30.9% of patients were adherent, and the mean (standard deviation) medication possession ratio was 0.499 (0.361). About 53.0% of patients persisted insulin therapy during follow-up, and the mean time to nonpersistence was 230.3 (145.5) days. Patients initiated with analog were more likely to be adherent (adjusted odds ratio: 1.07, =0.036) and persistent (adjusted hazard ratio: 0.88, <0.001) compared with those initiated with human insulin. Patients initiation with basal insulin had lower adherence relative to premixed (adjusted odds ratio: 0.79, <0.001). Patients comorbid with hypertension or dyslipidemia, initiated with prandial insulin, and with baseline severe hypoglycemic events were more likely to be nonadherent/nonpersistent.
The insulin adherence and persistence among Chinese patients with T2D are generally poor. Initiation with insulin analog or premixed insulin may result in better adherence/persistence to insulin therapy.
评估中国初治2型糖尿病(T2D)患者胰岛素治疗的依从性和持续性,并确定其相关因素。
使用天津市城镇职工基本医疗保险理赔数据库(2008 - 2011年)。纳入2009年1月至2010年12月开始胰岛素治疗、在起始前(基线)连续参保12个月且起始后(随访)连续参保12个月的成年T2D患者。药物持有率≥80%的患者被视为依从性好,胰岛素治疗无≥90天间断的患者被视为持续性好。通过单因素和多因素分析检测胰岛素依从性和持续性的相关因素。
共纳入24,192例患者;患者平均年龄58.9岁,女性占49.5%。约51.9%的患者起始治疗使用人胰岛素,39.1%起始使用胰岛素类似物,9.0%起始使用动物源性胰岛素。与基础胰岛素(11.8%)和餐时胰岛素(10.9%)相比,预混胰岛素(77.3%)的处方率最高。只有30.9%的患者依从性好,平均(标准差)药物持有率为0.499(0.361)。约53.0%的患者在随访期间持续胰岛素治疗,非持续性的平均时间为230.3(145.5)天。与起始使用人胰岛素的患者相比,起始使用胰岛素类似物的患者更有可能依从(调整后的优势比:1.07,=0.036)和持续(调整后的风险比:0.88, <0.001)。与预混胰岛素相比,起始使用基础胰岛素的患者依从性较低(调整后的优势比:0.79, <0.001)。合并高血压或血脂异常、起始用餐时胰岛素以及有基线严重低血糖事件的患者更有可能不依从/不持续。
中国T2D患者的胰岛素依从性和持续性普遍较差。起始使用胰岛素类似物或预混胰岛素可能导致更好的胰岛素治疗依从性/持续性。